But this hasn't stopped health insurers from continuing to argue that prescription drug costs are fueling rising health insurance premiums. Now, some consumer groups are starting to question these claims. According to a new story published on California Healthline, the advocacy group
Consumers have reason to be skeptical.
"Preliminary data indicate that drugs are not likely to have a disproportionate impact on premiums in 2017," Avalere said, highlighting that outpatient spending continues to drive premiums (representing 29.9 percent of increases).
Read more about how the competitive marketplace for medicines helps control costs and fosters the development of tomorrow's cures at phrma.org/cost.
This post originally appeared here: http://catalyst.phrma.org/are-insurers-exaggerating-medicine-costs-to-justify-premium-increases-consumers-think-so
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/are-insurers-exaggerating-medicine-costs-to-justify-premium-increases-consumers-think-so-300325538.html